Clinical trials
Completed Phase 3 trials in Saudi Arabia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
128 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 4 |
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 5 |
| 2008 | 5 |
| 2009 | 8 |
| 2010 | 5 |
| 2011 | 7 |
| 2012 | 7 |
| 2013 | 6 |
| 2014 | 8 |
| 2015 | 4 |
| 2016 | 5 |
| 2017 | 9 |
| 2018 | 13 |
| 2019 | 5 |
| 2020 | 7 |
| 2021 | 6 |
| 2022 | 7 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 128 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 18 |
| Hoffmann-La Roche | 14 |
| AstraZeneca | 8 |
| Imam Abdulrahman Bin Faisal University | 5 |
| King Faisal Specialist Hospital & Research Center | 4 |
| Pfizer | 4 |
| Australian and New Zealand Intensive Care Research Centre | 3 |
| King Abdulaziz University | 3 |
| King Saud University | 3 |
| McMaster University | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 9 |
| Diabetes Mellitus, Type 2 | 5 |
| Obesity | 5 |
| Asthma | 4 |
| Hemophilia A | 4 |
| Arthritis, Rheumatoid | 3 |
| Critical Illness | 3 |
| Graft vs Host Disease | 3 |
| Hepatitis C, Chronic | 3 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
Trials
Showing 1 to 25 of 128. Each trial links to its page on Pharma Observatory.
28 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.